ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 122

$337K Total Retail Price of All Prescriptions

Rank: 42 out of 122

259 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 259 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

16% of this provider’s 259 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 4,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LISINOPRIL 365 254 1 2
SIMVASTATIN 363 243 2 1
HYDROCODONE-ACETAMINOPHEN 226 81 S3 3 16
LEVOTHYROXINE SODIUM 210 169 4 4
OMEPRAZOLE 197 120 5 3
FUROSEMIDE 165 151 6 5
HYDROCHLOROTHIAZIDE 161 121 7 6
AMLODIPINE BESYLATE 156 141 8 7
RANITIDINE HCL 156 101 8 39
ATENOLOL 132 75 10 10
METFORMIN HCL 118 79 11 14
TRAMADOL HCL 106 51 12 20
GABAPENTIN 94 43 13 12
LOSARTAN POTASSIUM 84 77 14 17
METOPROLOL TARTRATE 82 75 15 8
DIOVAN 80 68 16 40
TRAZODONE HCL 79 18 17 21
ZOLPIDEM TARTRATE 78 55 18 19
METOPROLOL SUCCINATE 77 65 19 11
WARFARIN SODIUM 73 65 20 9
OXYBUTYNIN CHLORIDE 72 39 21 107
ALENDRONATE SODIUM 71 68 22 35
SERTRALINE HCL 70 39 23 18
VENLAFAXINE HCL ER 70 31 23 54
NEXIUM 69 30 25 32
CITALOPRAM HBR 66 24 26 15
ADVAIR DISKUS 64 45 27 34
ALLOPURINOL 63 49 28 33
LOVASTATIN 61 49 29 28
FENTANYL 59 42 S2 30 47
CARVEDILOL 57 47 31 56
METFORMIN HCL ER 53 50 32 84
PROAIR HFA 51 41 33 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 12, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.